Established in 2003, Keystone Clinical Studies is an independent clinical research site that conducts Phase 2, 3 and 4 clinical trials. At KCS, our mission is to help improve the lives of individuals, families, and their communities through the development of new medications for neuropsychiatric disorders.
Partial Data by Infogroup (c) 2024. All rights reserved.